The population prevalence of Down syndrome in Trentino region (Northeast Italy) in 2025
European Journal of Public Health · 09.10.2026 · 36 (6)
DOI: 10.1093/eurpub/ckag207 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, online erschienen am 13.11.2026. Verfasst von Riccardo Pertile und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Evaluative Epidemiology, Integrated University Health Authority of Trentino-ASUIT, Trento, Italy. Hauptthemen laut MEDLINE: Down Syndrome. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Down syndrome (DS) is the most common autosomal aneuploidy compatible with postnatal survival and the leading genetic cause of intellectual disability worldwide. In Italy, reliable population-based prevalence estimates are still lacking at both national and regional levels. We conducted a population-based study in the Trentino region using a multisource record-linkage approach. Individuals with DS born from 1945 onwards were identified through multiple health, administrative and social databases, including the Congenital Anomalies Registry (EUROCAT member). Vital status was ascertained up to 1 January 2025. Birth prevalence (1960–2025 and 1990–2025) and point prevalence were calculated, stratified by age and sex. As of 1 January 2025, 403 individuals with DS were resident in Trentino, corresponding to a prevalence of 7.37 per 10 000 inhabitants [95% confidence interval (CI) 6.65–8.09]. Birth prevalence trends showed a decrease in live births with DS over time, alongside an increase in terminations of pregnancy for foetal anomaly, while total birth prevalence (including terminations) increased. In 2020–2025, total birth prevalence was 35.4 per 10 000 births and 10.1 per 10 000 for live births only. Among individuals aged 5–49 years, prevalence appeared relatively constant across age groups, with no evidence of a linear trend with age. This is the first Italian population-based study providing a direct prevalence estimate of DS in a well-defined area using an integrated multisource approach. The observed prevalence is consistent with other high-income countries and reflects reduced live births and improved survival. These findings highlight the need for healthcare systems to address the growing adult population with DS and support evidence-based planning of services.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical and Evaluative Epidemiology, Integrated University Health Authority of Trentino-ASUIT, Trento, Italy.
- Medical Genetics Unit, Multi-zone Clinical Pathology Laboratory Unit, Department of Laboratories, Integrated University Health Authority of Trentino-ASUIT, Trento, Italy.
- Institute of Clinical Physiology, National Research Council, Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Pisa, Italy.
ORCID-Profile: Riccardo Pertile
Zitieren
APA
Pertile, R., Rivieri, F., Santoro, M., & Mantovani, W. (2026). The population prevalence of Down syndrome in Trentino region (Northeast Italy) in 2025. European Journal of Public Health, 36(6). https://doi.org/10.1093/eurpub/ckag207
Vancouver
Pertile R, Rivieri F, Santoro M, Mantovani W. The population prevalence of Down syndrome in Trentino region (Northeast Italy) in 2025. European Journal of Public Health. 2026;36(6). doi:10.1093/eurpub/ckag207
BibTeX
@article{Pertile2026,
author = {Pertile, Riccardo and Rivieri, Francesca and Santoro, Michele and Mantovani, William},
title = {The population prevalence of Down syndrome in Trentino region (Northeast Italy) in 2025},
journal = {European Journal of Public Health},
year = {2026},
volume = {36},
number = {6},
doi = {10.1093/eurpub/ckag207}
}
EUVIMED